Literature DB >> 1550436

[ST segment elevation in anterior precordial leads and right ventricular infarction. Apropos of 6 cases].

G Grollier1, P Scanu, M Gofard, T Lognoné, B Valette, G Bureau, P Commeau, J C Potier.   

Abstract

ST segment elevation in the anterior precordial chest leads may be observed in some cases of right ventricular infarction alone or associated with left ventricular inferior wall infarction. Six out of 700 patients admitted to our Coronary Care Unit over a 2 year period had right ventricular infarction with these electrocardiographic changes. In three cases, isolated right ventricular infarction was due to occlusion of a right marginal artery (N = 2) or of a small right coronary artery (N = 1) which only vascularised the right ventricle. In 2 cases, right ventricular infarction was associated with a recent or chronic left ventricular inferior wall infarct. This type of ST segment elevation may suggest a left ventricular anterior wall infarct especially when there are no changes in the inferior leads, as was the case in our first patient. However, the dome-like appearance of the ST segment, the reduction in amplitude of ST elevation from V2 to V5, the progressive regression of the ST changes without the appearance of Q waves, are more suggestive of the diagnosis of right ventricular infarction. In addition, normal left ventricular dilatation on echocardiographic examination rapidly confirms the diagnosis.

Entities:  

Mesh:

Year:  1992        PMID: 1550436

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  2 in total

1.  Ruptured sinus of Valsalva aneurysm presenting as ST-elevation myocardial infarction.

Authors:  Alistair C Lindsay; Balakrishnan Mahesh; Jullien A Gaer; Miles C D Dalby
Journal:  Nat Rev Cardiol       Date:  2009-05       Impact factor: 32.419

2.  Proximal complete occlusion of right coronary artery presenting with precordial ST-segment elevation: A case report.

Authors:  Jianlei Zheng; Jingyang Lin; Naiji Shen; Baiming Qu
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.